© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to July
low α- M1R positive allosteric modulator
7.5 mg+ PO QD in Ph. II for Parkinson’s
from eval. of M1R PAMs w/ low cooperativity
British Journal of Clinical Pharmacology
Takeda Pharmaceutical, Cambridge, USA
The Takeda brain-penetrant M1R positive allosteric modulator (PAM), TAK-071, was optimized for lower cooperativity (α) with the native ligand to theoretically reduce the side effect of diarrhea from M1R…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.